1. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
- Author
-
Auerbach MB, Shimoda N, Amano H, Rosenblum JM, Kish DD, Farber JM, and Fairchild RL
- Subjects
- Animals, Chemokine CXCL9 genetics, Chemokine CXCL9 immunology, Chemotaxis, Leukocyte immunology, Flow Cytometry, Graft Survival immunology, Histocompatibility Antigens Class II genetics, Immunohistochemistry, Interferon-gamma immunology, Lymphocyte Culture Test, Mixed, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Monokines biosynthesis, Monokines genetics, Monokines immunology, T-Lymphocytes immunology, Chemokine CXCL9 biosynthesis, Graft Rejection immunology, Skin Transplantation immunology, Transplantation, Homologous immunology
- Abstract
Chemokines, including monokine induced by interferon-gamma (Mig/CXCL9), are produced both in allografts and during the direct T-cell infiltration that mediates graft rejection. Neither the specific production nor contribution of allograft donor versus recipient Mig in allograft rejection is currently known. C57BL/6 mice with a targeted deletion in the Mig gene were used as both skin allograft donors and recipients in a class II major histocompatibility complex-mismatched graft model to test the requirement for donor- versus recipient-derived Mig for acute rejection. B6.Mig(-/-) allografts had a 10-day prolonged survival in B6.H-2(bm12) recipients when compared with wild-type C57BL/6 allograft donors, and B6.H-2(bm12) skin allografts had a 5-day prolonged survival in B6.Mig(-/-) versus wild-type recipients. Transplantation of B6.Mig(-/-) skin grafts onto B6.H-2(bm12).Mig(-/-) recipients resulted in further prolonged allograft survival with more than 30% of the grafts surviving longer than 60 days. Prolonged allograft survival was also associated with delayed cellular infiltration into grafts but not with altered T-cell proliferative responses to donor stimulators. Immunohistochemical staining of allograft sections indicated that Mig is produced by both donor- and recipient-derived sources, but Mig from each of these sources appeared in different areas of the allograft tissue. These results therefore demonstrate the synergy of donor- and recipient-derived Mig in promoting T-cell infiltration into allografts.
- Published
- 2009
- Full Text
- View/download PDF